Jarno Salonen
Jarno Salonen
Department of Physics and Astronomy, University of Turku, Finland
Verified email at
Cited by
Cited by
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ...
Journal of controlled release 108 (2-3), 362-374, 2005
Mesoporous silicon in drug delivery applications
J Salonen, AM Kaukonen, J Hirvonen, VP Lehto
Journal of pharmaceutical sciences 97 (2), 632-653, 2008
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ...
ACS nano 4 (6), 3023-3032, 2010
Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices
N Genina, J Holländer, H Jukarainen, E Mäkilä, J Salonen, N Sandler
European Journal of Pharmaceutical Sciences 90, 53-63, 2016
Mesoporous silica material TUD-1 as a drug delivery system
T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ...
International journal of pharmaceutics 331 (1), 133-138, 2007
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ...
Drug delivery 14 (6), 337-347, 2007
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
MA Shahbazi, M Hamidi, EM Mäkilä, H Zhang, PV Almeida, ...
Biomaterials 34 (31), 7776-7789, 2013
Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering
M Kaasalainen, V Aseyev, E von Haartman, DŞ Karaman, E Mäkilä, ...
Nanoscale research letters 12, 1-10, 2017
Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods
T Limnell, HA Santos, E Mäkilä, T Heikkilä, J Salonen, DY Murzin, ...
Journal of pharmaceutical sciences 100 (8), 3294-3306, 2011
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications
J Salonen, VP Lehto
Chemical engineering journal 137 (1), 162-172, 2008
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
Multistaged nanovaccines based on porous silicon@ acetalated dextran@ cancer cell membrane for cancer immunotherapy
F Fontana, MA Shahbazi, D Liu, H Zhang, E Mäkilä, J Salonen, ...
Adv Mater 29 (7), 1603239, 2017
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ...
Biomaterials 32 (10), 2625-2633, 2011
Semimetallic TiO2 Nanotubes
R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ...
Angewandte Chemie International Edition 48 (39), 7236-7239, 2009
Stabilization of porous silicon surface by thermal decomposition of acetylene
J Salonen, M Björkqvist, E Laine, L Niinistö
Applied Surface Science 225 (1-4), 389-394, 2004
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution
M Sarparanta, LM Bimbo, J Rytkonen, E Makila, TJ Laaksonen, ...
Molecular pharmaceutics 9 (3), 654-663, 2012
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
D Liu, LM Bimbo, E Mäkilä, F Villanova, M Kaasalainen, ...
Journal of Controlled Release 170 (2), 268-278, 2013
Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
P Kinnari, E Mäkilä, T Heikkilä, J Salonen, J Hirvonen, HA Santos
International journal of pharmaceutics 414 (1-2), 148-156, 2011
Multifunctional porous silicon nanoparticles for cancer theranostics
CF Wang, MP Sarparanta, EM Mäkilä, MLK Hyvönen, PM Laakkonen, ...
Biomaterials 48, 108-118, 2015
The system can't perform the operation now. Try again later.
Articles 1–20